Suppr超能文献

长链非编码RNA Morrbid在疾病发病机制中的当前见解与未来方向

Current insights and future directions of LncRNA Morrbid in disease pathogenesis.

作者信息

Yang Haiqiong, Gao Jiali, Zheng Zaiyong, Yu Yang, Zhang Chunxiang

机构信息

Department of Cardiology, The Affiliated Hospital, Southwest Medical University, Luzhou, China.

Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China.

出版信息

Heliyon. 2024 Aug 22;10(17):e36681. doi: 10.1016/j.heliyon.2024.e36681. eCollection 2024 Sep 15.

Abstract

Non-coding RNAs have emerged as important regulators of gene expression and contributors to many diseases. LncRNA Morrbid, a long non-coding RNA, has been widely studied in recent years. Current literature reports that lncRNA Morrbid is involved in various diseases such as tumors, cardiovascular diseases, inflammatory diseases and metabolic disorder. However, controversial conclusions exist in current studies. As a potential therapeutic target, it is necessary to comprehensively review the current evidence. In this work, we carefully review the literature on Morrbid and discuss each of the hot topics related to lncRNA Morrbid.

摘要

非编码RNA已成为基因表达的重要调节因子,并与许多疾病的发生有关。长链非编码RNA Morrbid近年来受到广泛研究。目前的文献报道,lncRNA Morrbid参与了肿瘤、心血管疾病、炎症性疾病和代谢紊乱等多种疾病。然而,目前的研究存在争议性结论。作为一个潜在的治疗靶点,有必要全面回顾当前的证据。在这项工作中,我们仔细回顾了关于Morrbid的文献,并讨论了与lncRNA Morrbid相关的每个热点话题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2903/11388785/288dcd95d3b4/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验